Literature DB >> 19389064

Enzymatic characterisation of clinical isolates of Cryptococcus neoformans, Cryptococcus gattii and other environmental Cryptococcus spp.

M Y Chan1, S T Tay.   

Abstract

This study compared the enzymatic activity of clinical isolates of Cryptococcus neoformans, Cryptococcus gattii, environmental isolates of C. neoformans and non-neoformans Cryptococcus. Most of the cryptococcal isolates investigated in this study exhibited proteinase and phospholipase activities. Laccase activity was detected from all the C. neoformans and C. gattii isolates, but not from the non-neoformans Cryptococcus isolates. There was no significant difference in the proteinase, phospholipase and laccase activities of C. neoformans and C. gattii. However, significant difference in the enzymatic activities of beta-glucuronidase, alpha-glucosidase, beta-glucosidase and N-acetyl-beta-glucosaminidase between C. neoformans and C. gattii isolates was observed in this study. Environmental isolates of C. neoformans exhibited similar enzymatic profiles as the clinical isolates of C. neoformans, except for lower proteinase and laccase activities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19389064     DOI: 10.1111/j.1439-0507.2008.01654.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  6 in total

1.  Antifungal susceptibility, enzymatic activity, PCR-fingerprinting and ITS sequencing of environmental Cryptococcus laurentii isolates from Uberaba, Minas Gerais, Brazil.

Authors:  Kennio Ferreira-Paim; Leonardo Andrade-Silva; Delio Jose Mora; Eliane Lages-Silva; André Luiz Pedrosa; Paulo Roberto da Silva; Anderson Assunção Andrade; Mario León Silva-Vergara
Journal:  Mycopathologia       Date:  2011-11-25       Impact factor: 2.574

2.  Repression of Proteases and Hsp90 Chaperone Expression Induced by an Antiretroviral in Virulent Environmental Strains of Cryptococcus neoformans.

Authors:  Cleber Fernando Serafin; Ana Paula Paris; Claudete Rodrigues Paula; Rita Cássia Garcia Simão; Rinaldo Ferreira Gandra
Journal:  Microb Ecol       Date:  2016-12-02       Impact factor: 4.552

3.  Integrated Activity and Genetic Profiling of Secreted Peptidases in Cryptococcus neoformans Reveals an Aspartyl Peptidase Required for Low pH Survival and Virulence.

Authors:  Starlynn C Clarke; Phillip A Dumesic; Christina M Homer; Anthony J O'Donoghue; Florencia La Greca; Lenka Pallova; Pavel Majer; Hiten D Madhani; Charles S Craik
Journal:  PLoS Pathog       Date:  2016-12-15       Impact factor: 6.823

4.  In Vitro Antifungal Susceptibility of Environmental Isolates of Cryptococcus spp. from the West Region of Cameroon.

Authors:  William Dongmo; Frederick Kechia; Roland Tchuenguem; Claude Nangwat; Iwewe Yves; Jules-Roger Kuiate; Jean Paul Dzoyem
Journal:  Ethiop J Health Sci       Date:  2016-11

5.  Cryptococcal Protease(s) and the Activation of SARS-CoV-2 Spike (S) Protein.

Authors:  Nozethu Mjokane; Maphori Maliehe; Olufemi S Folorunso; Adepemi O Ogundeji; Onele M N Gcilitshana; Jacobus Albertyn; Carolina H Pohl; Olihile M Sebolai
Journal:  Cells       Date:  2022-01-27       Impact factor: 6.600

6.  Genome-Wide Transcription Study of Cryptococcus neoformans H99 Clinical Strain versus Environmental Strains.

Authors:  Elaheh Movahed; Komathy Munusamy; Grace Min Yi Tan; Chung Yeng Looi; Sun Tee Tay; Won Fen Wong
Journal:  PLoS One       Date:  2015-09-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.